BST2, a type II transmembrane protein also known as HM1.24/CD317, has been identified to be overexpressed in a variety of cell lines from different cancer types, including multiple myeloma, breast, lung, and kidney cancers [26–29]. The gene discussed is BST2; the disease is kidney cancer.